The Food and Drug Administration officially approved a drug called flibanserin designed to treat women with hypoactive sexual desire disorder. The drug will be manufactured by Sprout Pharmaceuticals and will officially be sold under the name ‘Addyi.’
Well this is hopeful, if annoying: flibanserin, a drug developed by Sprout Pharmaceuticals to treat women’s low libido, is aiming again this week for FDA approval. And, as we reported in the past, tsk-tsk-ers at the agency are worried about “risks outweighing the rewards.”
The makers of a female Viagra-type pill are re-submitting their application to the Food and Drug Administration, though it's already been rejected twice. If approved, Sprout Pharmaceuticals' pill would be the first of its kind for women with libido issues.
